Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/173322
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTorras, M. G.-
dc.contributor.authorCanals, E.-
dc.contributor.authorMuñoz Montplet, C.-
dc.contributor.authorVidal, A.-
dc.contributor.authorJurado, D.-
dc.contributor.authorEraso Urién, Arantxa-
dc.contributor.authorVillà, S.-
dc.contributor.authorCaro, M.-
dc.contributor.authorMolero, J.-
dc.contributor.authorMacià, M.-
dc.contributor.authorPuigdemont, M.-
dc.contributor.authorGonzález Muñoz, Elena-
dc.contributor.authorGuedea Edo, Ferran-
dc.contributor.authorBorràs Andrés, Josep Maria-
dc.date.accessioned2021-01-21T13:55:47Z-
dc.date.available2021-01-21T13:55:47Z-
dc.date.issued2020-
dc.identifier.issn1748-717X-
dc.identifier.urihttp://hdl.handle.net/2445/173322-
dc.description.abstractIntroduction: Colorectal cancer treatment requires a complex, multidisciplinary approach. Because of the potential variability, monitoring through clinical audits is advisable. This study assesses the effects of a quality improvement action plan in patients with locally advanced rectal cancer and treated with radiotherapy. Methods: Comparative, multicentre study in two cohorts of 120 patients each, selected randomly from patients diagnosed with rectal cancer who had initiated radiotherapy with a curative intent. Based on the results from a baseline clinical audit in 2013, a quality improvement action plan was designed and implemented; a second audit in 2017 evaluated its impact. Results: Standardised information was present on 77.5% of the magnetic resonance imaging (MRI) staging reports. Treatment strategies were similar in all three study centres. Of the patients whose treatment was interrupted, just 9.7% received a compensation dose. There was an increase in MRI re-staging from 32.5 to 61.5%, and a significant decrease in unreported circumferential resection margins following neoadjuvant therapy (ypCRM), from 34.5 to 5.6% (p < 0.001). Conclusions: The comparison between two clinical audits showed improvements in neoadjuvant radiotherapy in rectal cancer patients. Some indicators reveal areas in need of additional efforts, for example to reduce the overall treatment time.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/S13014-020-1465-z-
dc.relation.ispartofRadiation Oncology, 2020, vol. 15-
dc.relation.urihttps://doi.org/10.1186/S13014-020-1465-z-
dc.rightscc-by (c) Torra, M. G. et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationCàncer colorectal-
dc.subject.classificationRadioteràpia-
dc.subject.otherColorectal cancer-
dc.subject.otherRadiotherapy-
dc.titleImproving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec696254-
dc.date.updated2021-01-21T13:55:47Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid32005123-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
696254.pdf540.94 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons